Nuwellis Approves Reverse Stock Split at Meeting

Nuwellis ( (NUWE) ) just unveiled an update.

On May 20, 2025, Nuwellis held its annual stockholders meeting where key decisions were made. Two Class III directors were elected to the board for three-year terms, and a reverse stock split was approved to help maintain compliance with Nasdaq listing requirements. Additionally, Baker Tilly US, LLP was ratified as the independent public accounting firm for 2025, and provisions were made for potential adjournments to gather more proxy votes if needed.

The most recent analyst rating on (NUWE) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Nuwellis stock, see the NUWE Stock Forecast page.

Spark’s Take on NUWE Stock

According to Spark, TipRanks’ AI Analyst, NUWE is a Neutral.

Nuwellis presents a mixed outlook with significant financial challenges due to ongoing losses and negative cash flows, despite stable revenue and strategic positioning in critical care. Technical indicators show neutrality, and valuation metrics reflect poor profitability. Strategic agreements and earnings call insights offer cautious optimism, but challenges in profitability and market demand remain critical hurdles.

To see Spark’s full report on NUWE stock, click here.

More about Nuwellis

Average Trading Volume: 79,673

Technical Sentiment Signal: Sell

Current Market Cap: $4.18M

See more data about NUWE stock on TipRanks’ Stock Analysis page.